Jeffrey W. Sherman, Director: Larimar Therapeutics LRMR Buy · Filed 03/02

Trade details

Type: Insider buy
Amount: $25,000
Shares · price: 5,000 sh · $5.00 a share
Held after: 5,000 sh
Stock: Larimar Therapeutics LRMR
Person: Jeffrey W. ShermanDirector
Trade date: 26/02/27
Filed: 26/03/02
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 13 insiders

Larimar Therapeutics trades, last 26 weeks

What else happened in Larimar Therapeutics around then

Filed or reported within 30 days of the trade day · 01/28~03/29

Jeffrey W. Sherman's recent trades

Jeffrey W. ShermanDirector
SellXeris Biopharma Holdings
Sell
Xeris Biopharma Holdings
XERS
$334.5K
42,232 sh
$334.5K
Filed 25/08/29
Traded 25/08/28
Jeffrey W. ShermanDirector
Planned saleXeris Biopharma Holdings
Planned sale
Xeris Biopharma Holdings
XERS
$334.5K
42,232 sh
$334.5K
Filed 25/08/28
Traded 25/08/28
Jeffrey W. ShermanDirector
BuyXeris Biopharma Holdings
Buy
Xeris Biopharma Holdings
XERS
$10.1K
5,400 sh
$10.1K
Filed 23/11/29
Traded 23/11/27
Jeffrey W. ShermanEVP and Chief Medical Officer
SellHorizon Therapeutics Public
Sell
Horizon Therapeutics Public
HZNP
$380.8K
3,368 sh
$380.8K
Filed 23/01/12
Traded 23/01/10
Jeffrey W. ShermanEVP and Chief Medical Officer
SellHorizon Therapeutics Public
Sell
Horizon Therapeutics Public
HZNP
$380.9K
3,368 sh
$380.9K
Filed 23/01/12
Traded 23/01/11